Results 1 to 10 of about 16,010 (164)
Purpose: To report a patient with resistant cystoid macular edema after an uneventful phacoemulsification cataract surgery who responded to subconjunctival interferon α2b injections.
Hossein Aghaei +2 more
doaj +1 more source
Background Cystoid macular edema is a rare, vision-threatening side effect of the taxane family of anticancer agents. There is no established treatment or standard treatment protocol for taxane-related cystoid macular edema.
Mitsuru Otsubo +3 more
doaj +1 more source
Introduction This study aimed to investigate the prevalence of cystoid macular edema after pars plana vitrectomy for the treatment of pseudophakic rhegmatogenous retinal detachment and identify possible related risk factors.
Federico Bernabei +7 more
doaj +1 more source
Background Cystoid macular edema is a known complication of omidenepag isopropyl usage. Omidenepag isopropyl is a selective prostanoid EP2 receptor agonist, and its association with macular edema has mainly been identified in pseudophakic eyes.
Byung-Jin Bae +2 more
doaj +1 more source
Background The treatment of recurrent cystoid macular edema associated with acute retinal necrosis is challenging due to the concern that treatment with intravitreal steroids may reactivate the retinitis.
Ragnhild Øvstebø Sørland +5 more
doaj +1 more source
Risperidone-related bilateral cystoid macular edema: a case report
Background A report of the second known case of bilateral cystoid macular edema in a patient taking risperidone. Case presentation We report a case of a 69-year-old African American woman using risperidone who presented with worsening visual acuity and ...
Anna Kozlova +2 more
doaj +1 more source
Background To report a bilateral cystoid macular edema associated with Henoch-Schonleinpurpura. Case presentation A 21-year-old man presented a bilateral, painless, and bilateral blurred vision for 5 weeks with visual acuity (VA) of 6/12 on the right eye
Dongyan Pan +6 more
doaj +1 more source
Widening use of dexamethasone implant for the treatment of macular edema [PDF]
Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T. +9 more
core +2 more sources
Diabetic Macular Edema With and Without Subfoveal Neuroretinal Detachment: Two Different Morphologic and Functional Entities [PDF]
To assess specific morphologic and functional characteristics in eyes with diabetic macular edema (DME) with subfoveal neuroretinal detachment (SND+) vs DME without SND (SND-)
Berton, Marianna +5 more
core +1 more source
Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report [PDF]
Background Ozurdex is a 700 mcg dexamethasone intravitreal implant, approved for the management of macular edema secondary to retinal vein occlusion, and other related pathoglogiesAnterior chamber dislocation of Ozurdex represents an uncommon ...
AGOSTINELLI, Enzo +6 more
core +1 more source

